Results
1 -
8 of
8
(Click
here to explore results)
- Emerging Drugs and Targets for Multiple Sclerosis, CHAPTER 9 Emerging Drugs and Targets for Remyelination in Multiple Sclerosis. Laura J. Wagstaff, Anna Williams
, 2019
, Pages 197-221
- Polysaccharide-based Biomaterials: Delivery of Therapeutics and Biomedical Applications, Chapter 10 Pectin-based Vehicles for Delivery of Therapeutics. Roshan Keshari, Amarjitsing Rajput, Aditi Nandi, Riyaz Ali M. Osmani, Nadim Ahamad, Rinti Banerjee
, 2023
, Pages 269-298
- Anti-Inflammatory Drug Discovery, CHAPTER 2 Inhibitors of Cytosolic Phospholipase A2
α as Anti-inflammatory Drugs. MATTHIAS LEHR
, 2012
, Pages 35-57
- Therapeutic Oligonucleotides, Chapter 7 Decoy Oligodeoxynucleotides to Treat Inflammatory Diseases. Markus Hecker, Swen Wagner, Stefan W. Henning, Andreas H. Wagner
, 2008
, Pages 163-188
- Emerging Drugs and Targets for Multiple Sclerosis, Subject Index
, 2019
, Pages 327-333
- Electrospinning: From Basic Research to Commercialization, CHAPTER 5 Electrospun Fibers for Advanced Wound Care: Moving from Novel Lab-scale Curiosities to Commercial Realities. H. Kriel, M. P. Coates, A. E. Smit
, 2018
, Pages 95-135
- Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 3 Dermal Formulations for Local Treatment. Majella E. Lane, Nicola Parisi
, 2022
, Pages 75-93
- Drug Repurposing, Chapter 7 Cheminformatics Data Mining and Modeling for Drug Repurposing. S. Avram, R. Curpan, T. I. Oprea
, 2022
, Pages 129-146